ELISA
The firm plans to file for regulatory approval of its first test, a chemiluminescent ELISA for respiratory disease, as early as the first quarter of 2024.
Dynex Technologies to Distribute Tecan Immunoassay Products in US
Dynex offers a variety of fully automated ELISA microplate instruments that can run Tecan's ELISA and chemiluminescence assays.
OncoHost Raises $35M in Series C Financing
The Israeli firm will use the funds to expand its PROPHETIC trial and support the US commercial launch of the Prophet platform.
CardiNor Nabs CE Mark for Cardiovascular Risk Test
The test measures secretoneurin, a novel biomarker that predicts mortality in patients with cardiovascular disease.
New Biomarker, Test From Wash U Team Aims to ID Patients at Higher Risk of Cardiovascular Disease
Premium
The diagnostic blood test for elevated serum fatty acid synthase detected patients at risk of chronic limb-threatening ischemia with 83 percent accuracy.
Mar 19, 2021
Mar 3, 2021
Feb 19, 2021
Feb 11, 2021
Eurofins Gets CE Mark for Coronavirus Antibody Test
Feb 10, 2021
VolitionRx Prices $20M Public Offering
Jan 4, 2021
Oct 28, 2020
Biodesix Prices $72M IPO
Oct 23, 2020